News

Deal Announcements

Aquinox Pharmaceuticals Nets 2nd Venture Capital Round

Friday, June 18, 2010 5:57:00 AM PDT | VentureDeal Staff
Vancouver, British Columbia  --  Aquinox Pharmaceuticals has landed $25 million in its second round of institutional venture capital investment.

Aquinox is developing small molecule therapeutics targeting "SH2-containing inositol-5-phosphatase for the treatment of inflammatory disease and cancer."

Ventures West led the round, which also included The Pfizer Strategic Investments Group, Johnson & Johnson Development Corporation, Baker Brothers Investments and the BC Advantage Funds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1